BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2347245)

  • 1. A circulating myocardial depressant substance in septic shock.
    Chest; 1990 Jun; 97(6):1502-3. PubMed ID: 2347245
    [No Abstract]   [Full Text] [Related]  

  • 2. A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock.
    Reilly JM; Cunnion RE; Burch-Whitman C; Parker MM; Shelhamer JH; Parrillo JE
    Chest; 1989 May; 95(5):1072-80. PubMed ID: 2707065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial depressant substances in meningococcal septic shock.
    Kumar A; Parrillo JE
    Crit Care Med; 2002 Oct; 30(10):2379-80. PubMed ID: 12394974
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of adrenal cortex hormone in endotoxic shock, with special reference to its effect on cardiac function and myocardial depressant factor].
    Kosugi I; Yamaguchi Y; Kawaguchi T; Kawashima Y; Okada K
    Masui; 1976 Feb; 25(2):171-8. PubMed ID: 943602
    [No Abstract]   [Full Text] [Related]  

  • 5. Enterotoxic shock in rhesus monkeys. The role of selected bloodborne factors.
    Pettit GW; Yamada T; Wing DA; Jahrling PB
    Circ Res; 1978 Sep; 43(3):398-405. PubMed ID: 98239
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathophysiology of shock.
    Okada K; Kosugi I; Kitagaki T; Yamaguchi Y; Yoshikawa H
    Jpn Circ J; 1977 Apr; 41(4):346-61. PubMed ID: 875220
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of a myocardial depressant factor in meningococcal septicemia.
    Pathan N; Sandiford C; Harding SE; Levin M
    Crit Care Med; 2002 Oct; 30(10):2191-8. PubMed ID: 12394943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current status of the myocardial depressant factor (MDF) and shock].
    Favaro R; Pelaia P
    Minerva Anestesiol; 1979; 45(7-8):594-600. PubMed ID: 548819
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock.
    Pathan N; Hemingway CA; Alizadeh AA; Stephens AC; Boldrick JC; Oragui EE; McCabe C; Welch SB; Whitney A; O'Gara P; Nadel S; Relman DA; Harding SE; Levin M
    Lancet; 2004 Jan; 363(9404):203-9. PubMed ID: 14738793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial depression in septic shock: physiologic and metabolic effects of a plasma factor on an isolated heart.
    Maksad AK; Cha CJ; Stuart RC; Brosco FA; Clowes GH
    Surg Forum; 1978; 29():23-5. PubMed ID: 401143
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of acid base disturbance, septic shock, and calcium and phosphorous abnormalities on cardiovascular function.
    Mehta PM; Kloner RA
    Crit Care Clin; 1987 Oct; 3(4):747-58. PubMed ID: 3332222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Humoral factors in cardiogenic shock].
    Kölbel F; Veselý P
    Vnitr Lek; 1978 Jul; 24(7):657-60. PubMed ID: 676122
    [No Abstract]   [Full Text] [Related]  

  • 13. [Myocardial depressant factor in shock].
    Okada K; Kosugi I; Yamaguchi Y; Innami H; Kawashima Y
    Masui; 1973 May; 22(5):414-22. PubMed ID: 4737987
    [No Abstract]   [Full Text] [Related]  

  • 14. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.
    Parrillo JE; Burch C; Shelhamer JH; Parker MM; Natanson C; Schuette W
    J Clin Invest; 1985 Oct; 76(4):1539-53. PubMed ID: 4056039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed appearance of a circulating myocardial depressant factor in burn patients.
    De Santis D; Phillips P; Spath MA; Lefer AM
    Ann Emerg Med; 1981 Jan; 10(1):22-4. PubMed ID: 7458026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A low-molecular blood serum factor suppressing myocardial function in traumatic shock complicated by massive blood loss].
    Antonenko VT; Treshchinskiĭ AI; Korolev IuN; Shlapak IP
    Anesteziol Reanimatol; 1988; (5):42-4. PubMed ID: 3218778
    [No Abstract]   [Full Text] [Related]  

  • 17. Release of myocardial depressant factor (MDF) during cardiopulmonary bypass (CPB): influence of corticosteroids (methylprednisolone) and protease inhibitor (aprotinin).
    Coraim FI; Laufer G; Ilias W; Wollenek G; Wolner E
    Prog Clin Biol Res; 1987; 236A():611-20. PubMed ID: 2441410
    [No Abstract]   [Full Text] [Related]  

  • 18. [Endogenous shock substances: research trends].
    Okada K
    Nihon Rinsho; 1980; 38(4):1836-42. PubMed ID: 7411893
    [No Abstract]   [Full Text] [Related]  

  • 19. [Myocardial depressant factor in patients with low output syndrome].
    Senoo Y; Mondori E; Nawa S; Kawakami S; Teramoto S
    Kyobu Geka; 1977 Apr; 30(4):313-7. PubMed ID: 559194
    [No Abstract]   [Full Text] [Related]  

  • 20. Modified paper chromatographic method for assay of myocardial depressant factor.
    Yamada T; Pettit GW
    Circ Shock; 1977; 4(4):379-86. PubMed ID: 598007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.